Cherington Charles
SEC CIK 1448698 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | Dir, 10% | 6.78M | $5.36M | — | 8 | 2021-06-01 | 2026-02-10 |
Most active insiders at ERNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cherington Charles | 10% | $2.00M | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-10 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.5 | +4.00M | 6.78M | +144% | +$2.00M |
| 2025-06-11 | 2025-06-09 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.1 | +21.24M | 41.66M | +104% | +$2.12M | |
| DMA | 2025-05-07 | 2024-09-24 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | — | +13.25M | 818.2K | New | — |
| 2025-04-04 | 2025-04-02 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.1 | +3.77M | 20.40M | +23% | +$376.8K | |
| DM | 2024-11-05 | 2024-10-29 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | — | +13.25M | 818.2K | New | — |
| D | 2024-11-05 | 2024-10-29 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | C - Cnv Deriv | $0.5 | +2.82M | 16.63M | +20% | +$1.41M |
| D | 2022-12-06 | 2022-12-02 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | Dir, 10% | P - Purchase | $3.28 | +261.8K | 556.5K | +89% | +$858.6K |
| D | 2021-12-10 | 2021-06-01 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | Dir | J - Other | $0.00 | +92 | 5.89M | +0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations